See the target.
Ultrasound guidance supports real-time visualization during treatment planning and delivery.
Turning sound into a new path for cancer care.
SONIRE is developing next-generation ultrasound-guided HIFU therapy designed to focus energy precisely where it matters.
Explore the technology
FDA Breakthrough Device DesignationSUNRISE-II U.S. clinical studyPalo Alto + TokyoUltrasound-guided HIFUFDA Breakthrough Device DesignationSUNRISE-II U.S. clinical studyPalo Alto + TokyoUltrasound-guided HIFU
The idea
A less invasive treatment modality, built around focused sound.
High-intensity focused ultrasound can concentrate acoustic energy inside the body. SONIRE is developing its system to combine ultrasound guidance, cavitation-enhanced visualization and robotic positioning.
Focus the energy.
HIFU concentrates energy at a focal region rather than using a surgical incision.
Move with precision.
Robot guidance supports fine positioning of the irradiation point and intuitive operation.
Interactive technology story
Sound converges.
Energy focuses.
SONIRE’s approach uses focused ultrasound to heat a defined target area while ultrasound guidance helps clinicians visualize and position the treatment.
See how HIFU worksSONIRE Suizenji platform
Platform
Technology designed for difficult-to-treat cancers.
Pancreatic cancer is SONIRE’s first target as the company advances clinical development in Japan and the United States.
01Ultrasound-guided HIFU
02Cavitation-enhanced visualization
03Robot-assisted positioning
Latest progress
From research platform to international clinical development.
From acoustic engineering to a new therapeutic future.
Explore the science, clinical development and people behind SONIRE’s next-generation HIFU platform.
Meet SONIRE